title: Atrial fibrillation: will new drugs and patient choice improve anticoagulation outcomes?
abstract: The growing epidemic of atrial fibrillation presents major challenges to the healthcare community, both clinical and financial.
authors.forename: R
authors.initials: R
authors.lastname: Fuller
authors.forename: N J
authors.initials: NJ
authors.lastname: Dudley
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D001384:Azetidines / Q000627:therapeutic use; D001596:Benzylamines; D006801:Humans; D010358:Patient Participation; D018570:Risk Assessment / Q000379:methods; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013917:Thrombin / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran; D013917:Thrombin